Vice President, Clinical and RegulatoryAffairs
Dr. Ywan-Feng Li is Vice President Clinical and Regulatory Affairs at United BioPharma (UBP). She leads the departments of Clinical/Medical and Regulatory Affairs responsible for the development of all UBP pipeline products. Since attaining her leadership role, Dr. Li has led the team to achieve several IND readiness and subsequent approvals with regulatory agencies in the United States, Taiwan, and China.
Prior to her career at UBP, Dr. Li was Director of division of pharmaceutical science in Centre of Drug Evaluation (CDE) in Taiwan and a senior reviewer of the biological products. During Dr. Li's tenure at CDE, her responsibilities included regulatory evaluation, training, and guidance of drugs toward IND and NDA. Dr. Li earned her Ph.D. in Biology from University of North Carolina at Chapel Hill in USA and her BSc degree in Aquaculture from National Taiwan Ocean University.